---
date: 2025-04-27
Rotations:
  - "[[02 Rotations/Intensive Care Unit|Intensive Care Unit]]"
  - "[[02 Rotations/Emergency Medicine|Emergency Medicine]]"
---
- See: [[Advanced Life Support|ALS]] notes
# Adrenaline
- Indication: Cardiac arrest—give immediately if bradyasystolic rhythm or after the second shock if VF/pVT
- Cautions: Ensure reliable IV access; do not use cardiac arrest dose in a patient with a pulse.
- Comments: Can be given via intraosseous route if IV access not available.
- Dose: Available in 1 mg ampoules or rapid-access syringes (1:1000 (equivalent 1 mg/mL) and 1:10,000 ampoules (equivalent 0.1 mg/mL) concentrations)
	- Adult: 
		- IV, intraosseous: ==1 mg rapid IV (using 1 mL of 1:1000 solution or 10 mL of 1:10,000 solution)== This is repeated every 3–5 min followed by a 20 mL normal saline flush to ensure central delivery of the drug (if using a peripheral vein)
		- IV infusion: ==1-4mcg/min==; seek specialist advice
	- Child:
		- IV, intraosseous: ==10mcg/kg (max: 1mg as single dose)== repeat every 3-5 min

![[Pasted image 20250426204816.png]]
# Amiodarone
- Also see: [[Antiarrhythmics]]
- Indication: Cardiac arrest—give following 3rd shock in refractory VF/pVT
- Adverse effects: may worsen bradyarrhythmias
- Cautions: Thrombophlebitis when injected into a peripheral vein. Not compatible with normal saline give with glucose 5%
- Comments: Can be given via intraosseous route if IV access not available
		- It is oily; shaking will cause bubbles and make it hard to draw up
- Dose: Available in 150 mg ampoules. 
	- **Give amiodarone 300 mg (6mL) IV or IO diluted in 5% dextrose up to 20 mL over 1-2 mins after the third shock**
		- Flush with 5% dextrose or 0.9% sodium chloride, minimum of 20mLs
	- Repeat 150 mg dose in 3–5 min if VF/pVT persists
	- An infusion may be ordered after bolus dose(s) e.g. 15mg/kg over 24 hours

![[Pasted image 20250427123044.png]]
# Calcium
- Indication: Cardiac arrest associated with hyperkalaemia (not due to digoxin toxicity), hypocalcaemia, calcium-channel blocker toxicity
- Cautions: Thrombophlebitis when injected into a peripheral vein. Not compatible with sodium bicarbonate → *Do not give calcium solutions and sodium bicarbonate simultaneously by the same route*
- Comments: Can be given via intraosseous route if IV access not available; flush well after use
- Dose: Available as 10% calcium chloride (6.8 mmol in 10 mL) and 10% calcium gluconate (2.2 mmol in 10 mL) ampoules
	- Cardiac arrest: 10 mL of Ca chloride or 30 mL of Ca gluconate as rapid IV bolus. Repeat in 3–5 min if no response

![[Pasted image 20250427123204.png]]
# Lignocaine
- Indication: Cardiac arrest -> give following 3rd shock in refractory VF/pVT if amiodarone unavailable
- Actions: Membrane-stabilising antiarrhythmic
- Adverse effects: Proarrhythmic -> may worsen bradyarrhythmias
- Comments: Can be given via intraosseous route if IV access not available
- Dose: Available 100mg ampoules or rapid access syringes
	- Cardiac arrest: 100mg rapid IV bolus. Repeat in 3-5 min if no response

![[Pasted image 20250427123312.png]]
# Magnesium
- Indication: Cardiac arrest associated with hypomagnesaemia, torsades de points or digoxin toxicity; third line agent in refractory VF/pVT
- Comments: Can be given intraosseous route if IV access not available
- Dose: Available as 0% magnesium sulfate ampoules (2.g/10mmol in 5mL)
	- Cardiac arrest: 10mmol rapid IV bolus. Repeat in 3-5 minutes if no response

![[Pasted image 20250427123451.png]]
# Sodium Bicarbonate
- Indication: Cardiac arrest assocaited with hyperkalaemia, sodium channel blocker activity toxicity (TCA overdose) or severe metabolic acidosis, protracted arrest (>15 minutes)
- Cautions: Not compatiable with calcium -> Do not give simultaneously by the same route
- Comments: Can be given via intraosseous route if IV access not available
- Dose: Available in 100mL of 8.4% (100mmol) ampoules or 50mL of 8.4% (50mmol) rapid-access syringes
	- Cardiac arrest: 50mmol rapid IV bolus. Repeat in 3-5 min if no response

![[Pasted image 20250427123823.png]]
# Potassium
- Indication: Persistent VF, documented hypokalaemia
- Dose: Bolus of 5mmol is given IV or IO

![[Pasted image 20250427123615.png]]
# Vasopressin
![[Pasted image 20250427123918.png]]